ABBV-295
A Study of ABBV-295 Subcutaneous Injections to Assess Pharmacokinetics and Adverse Events in Healthy Adult Women Participants With Overweight or Obesity Taking Oral Contraceptives
AbbVie · Phase 1 · Completed · Enrollment 20
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| ABBV-295 with Levonorgestrel and Ethinyl Estradiol | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.